The European Academy of Paediatrics exists to promote the health of children and young people in Europe. It aims to improve standards in training, service and research and to represent the professional interests of paediatricians in the EU. It closely collaborates with the European Union of Medical Specialists and therefor has influence in the political arena to advocate for children and young people as well as for the profession.
The EAP Vaccination Strategic Advisory Group (VSAG) consists of representatives from all European regions, who are involved in their national immunisation programmes, with the intention to build an effective and interactive network.
It’s not just about the knowledge shared; it’s the genuine connections you will make that set our events apart. Join us and see why being part of the Global EAP family is so inspiring.
EAP offers you many events at different times and in different European geographies. You can follow the events on our page.
The European Board of Paediatrics – EAP online examination (EBP-EAP) has been developed in collaboration with CESMA and UEMS to assess knowledge in essential paediatric training.
EAP (European Academy of Paediatrics, Paediatric section of UEMS) Strategic Advisory Group of ethics has been established as a regular working group in 1997 and since that time different members from EAP participated.
It is open to everybody and the main purpose is to join those members, who are interested in ethical issues in paediatrics.
During this period more than 30 papers have been published on different topics (readily available at the EAP webpage) and some statements on critical issues were launched to the health ministries of EU countries. Workshops have been organized to attract members and to share their different opinions on “hot issues & topics” within paediatric ethics.
Finally, the gathering in Ethics Strategic Advisory Group stimulates multicentre working principle and networking and such positive atmosphere already resulted in three multicentre research projects financed within EU programmes.
The highlight of the Choosing Wisely session at the Spring Meeting in Porto was the exciting presentation of the Choosing Wisely top 10 Recommendations to physicians. Susanne Suggs joined as a guest speaker, highlighting the innovative methods adopted by the EAP-Choosing Wisely team to disseminate recommendations, such as creating hashtags and QR codes for social media amplification and postcard-sized materials for distribution in medical practices. She spoke about how to leverage technology and consistent framing strategies contribute to promoting smarter medicine across different regions. The challenges and Strategies in Addressing Vaccine Hesitancy and the complexities of vaccine hesitancy were all touched on, emphasising the importance of tailored communication strategies to parents and acknowledging the influence of trust, cultural beliefs, and vaccine fatigue.
Primary care pediatrician Burgdorf, Swiss delegate European Academy of Paediatrics, active member of SMOPP (Swiss mongolianpediatricproject)
The Choosing Wisely Strategic Adivsory Group is an initiative ignited by the broader campaign led by the ABIM Foundation. The overarching aim is been to ignite conversations between clinicians and patients regarding the necessity of tests, treatments, and procedures. Originating in 2012 with nine national specialty societies representing 375,000 clinicians, the campaign initially presented 45 examples of commonly utilized tests or treatments lacking strong supporting evidence. Over the years, this initiative has evolved, with more than 80 specialty societies contributing additional examples until 2023. Societies, like EAP, have been encouraged to publish individual lists.
The Choosing Wisely group actively participates at EAP Spring and Winter Meetings.
“Choosing Wisely” is an international movement to promote conversations between clinicians and patients by helping patients choose care that is:
EAP has launched a working group for Choosing Wisely. On this website you will find resources, including a statement from EAP, recommendations from seven countries with paediatric initiatives and useful links.
If you want further information or to become a member of the working group, please contact us at secretariat@eapaediatrics.eu
The Choosing Wisely EAP Strategic Advisory Group is very happy to share the below documents, brochures and information from “Paediatrics Switzerland & Smarter Medicine (Choosing Wisely)”.
EVENT: 26-27 Oct 2024
Core Knowledge in Paediatrics Online Course 2024
Discover the EAP’s acclaimed Core Knowledge in Paediatrics, a 2-day online course that takes place over a weekend (Friday and Saturday) in the second half of October annually. This event, now in its fourth edition…
EVENT: 17-20 Oct 2024
The 10th Congress of the EAP Societies
Theme: “Harmony between cutting edge research and clinical care” Dear Colleagues, It is an honour and pleasure to invite you all to the 10th Congress of the European Academy of Paediatric Societies…
NEWS: 8 July 2024
Attacks on the national specialised children’s hospital in Kyiv.
The European Academy of Paediatrics and the European Confederation of Primary Care Paediatrics utterly condemn the rocket attacks on the National Specialised Children’s Hospital in Kyiv…
President, EAP
“Paediatrics and Child Health need a united, credible and strong voice in Europe”
USEFUL RESOURCES
AND LINKS
New ways to test high-risk medical devices.
Manufacturers of medical devices need to test their products before being allowed to market them. Specifically, they require clinical data showing their medical device is safe and efficient. In this context, the EU-funded CORE-MD project will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators. The project will propose how new trial designs can contribute and suggest ways to aggregate real-world data from medical device registries.
It will also conduct multidisciplinary workshops to propose a hierarchy of levels of evidence from clinical investigations, as well as educational and training objectives for all stakeholders, to build expertise in regulatory science in Europe. CORE–MD will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators, to achieve an appropriate balance between innovation, safety, and effectiveness. A unique collaboration between medical associations, regulatory agencies, notified bodies, academic institutions, patients’ groups, and health technology assessment agencies, will systematically review methodologies for the clinical investigation of high-risk medical devices, recommend how new trial designs can contribute, and advise on methods for aggregating real-world data from medical device registries with experience from clinical practice The consortium is led by the European Society of Cardiology and the European Federation of National Associations of Orthopaedics and Traumatology, and involves all 33 specialist medical associations that are members of the Biomedical Alliance in Europe.